Subcutaneous epcoritamab combined with R-CHOP for first-line treatment of patients with high-risk diffuse large b-cell lymphoma: phase 1/2 update
Authors
Lorenzo, F.Fritz, O.
David, B.
Joshua, B.
Linton, Kim M
Yasmin, K.
Raul, C.
Sylvia, S.
Aqeel, A.
Liwei, W.
Jun, W.
Brian, E.
Clausen, M. R.
Affiliation
Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York,New York, USA;Issue Date
2022